@xconomy.com 3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@medical_view 4 years ago
Scientists from @IRBBarcelona, @CRGenomica & @Radboud_Uni have developed an #machinelearning algorithm that can predict which cancer patients are more likely to benefit from #immunotherapy. @FranSupek @BenLehner #AIinHealth https://medicalview.org/ai-system-predicts-which-cancer-patients-benefit-from-immunotherapy/ https://t.co/6p7By58mo4
@xconomy.com 4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com 4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com 4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com 5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front